1:1 Consultation
Is Silhouette Soft FDA-Cleared? A US Patient's Guide
Is Silhouette Soft FDA-cleared? No. A related US product, Silhouette InstaLift, is cleared (K142061), but Silhouette Soft is not. Here is what that means.
Aube Clinic · Dr. Suhyun Kim, M.D. · Yongsan-gu, Seoul
1:1 Consultation →Medically reviewed by Dr. SuHyun Kim, Medical Director, Aube Clinic
If you are researching thread lifts before traveling to Korea, you have probably come across the name Silhouette Soft, and you may be wondering whether it is "FDA-cleared." This is a smart question to ask, because regulatory status is one of the most misunderstood parts of aesthetic medicine, and marketing language often blurs it. The short, accurate answer is this: Silhouette Soft, the brand used in Korea and other markets outside the United States, is not US-FDA-cleared. A related product sold in the US, Silhouette InstaLift, is US-FDA-cleared for a specific temporary midface indication — but it is not the same product, and it is not a facelift. This article explains exactly what that means, why the distinction matters, and how to think about regulatory claims as a US patient considering treatment abroad.
The precise answer
Let us be exact, because precision is the whole point here.
Silhouette Soft is a cone-type absorbable thread product used in various countries outside the United States, including Korea. It is not cleared or approved by the US Food and Drug Administration (FDA) for the US market. Being available and used in Korea does not mean it carries US-FDA status.
Silhouette InstaLift is a separate product marketed in the United States. It received FDA 510(k) clearance under number K142061 (granted in 2015). According to the FDA record, it is an absorbable suture device indicated for use in mid-face suspension surgery to fixate the cheek subdermis in an elevated position. That is a specific, limited indication — not a general claim that the product performs a "facelift," and not a statement that covers every possible cosmetic use.
So if someone tells you Silhouette Soft is "FDA-cleared," that is not accurate. What is accurate is that a related US product, Silhouette InstaLift, is FDA-cleared for a specific temporary midface fixation indication. The two names are close, and the underlying technology is related, but for regulatory purposes they are not interchangeable.
"Cleared" versus "approved": why the words matter
People often use "FDA-cleared" and "FDA-approved" as if they mean the same thing. They do not, and the difference is meaningful.
The FDA regulates medical devices using a risk-based system. Many moderate-risk (Class II) devices reach the US market through a pathway called 510(k) premarket notification. In a 510(k), the manufacturer demonstrates that the device is substantially equivalent to another device already legally marketed in the US. When the FDA agrees, the device is said to be "cleared." Silhouette InstaLift went through this 510(k) pathway, which is why it is described as cleared, not approved.
By contrast, "FDA-approved" generally refers to products (typically the highest-risk Class III devices, and drugs) that go through the more rigorous premarket approval (PMA) process, which requires independent evidence of safety and effectiveness, often including clinical trial data. Because Silhouette InstaLift is a 510(k)-cleared device, the correct term is "cleared." Using "approved" for it would be technically incorrect. This is not a trivial nitpick — the two words describe genuinely different levels and types of FDA review.
Clearance is always for a specific indication
Another common misunderstanding is treating FDA clearance as a broad, all-purpose seal of approval. It is not. A 510(k) clearance is tied to a specific intended use described in the FDA record. For Silhouette InstaLift, that cleared indication is mid-face suspension to fixate the cheek subdermis in an elevated position — a temporary, defined purpose.
That has two practical consequences. First, a cleared indication does not automatically extend to every area of the face or every cosmetic goal a patient might have. Using a device outside its cleared indication is a decision made by a licensed physician exercising clinical judgment, and it should be discussed openly. Second, a clearance for one product does not transfer to a differently named product. Silhouette InstaLift's clearance does not make Silhouette Soft "FDA-cleared."
Regulatory status differs from country to country
Here is a point that surprises many patients: a product's regulatory status is specific to each country. The US FDA governs what may be marketed in the United States. Korea has its own regulatory authority governing what may be used there. A thread product used routinely and legally in Korea is being used under Korean rules, which is entirely normal — it simply is not the same thing as holding US-FDA status.
This is why "Silhouette Soft is used in Korea" and "Silhouette Soft is FDA-cleared in the US" are two different statements, and only the first is true. Neither one, on its own, tells you the product is better or worse than any alternative. Regulatory clearance is about a defined pathway and indication in a specific jurisdiction — it is not a ranking, a guarantee of results, or a marketing trophy. There is no superiority claim to be drawn here in any direction.
What this means if you are a US patient considering treatment in Korea
None of this should alarm you, but it should make you a more informed consumer. If you are considering a thread lift at a clinic in Seoul, understand that the specific product used there may not carry US-FDA status, and that this is common and expected for treatments performed under another country's regulations. What matters most is that a qualified physician evaluates whether a thread lift suits your anatomy and goals, explains the realistic and temporary nature of the results, and reviews the risks with you honestly.
It also helps to keep expectations grounded. Thread lifts of any brand are minimally invasive and not a substitute for a surgical facelift. Absorbable threads reposition and support soft tissue and can prompt a gradual tissue response, but the effect is modest, gradual, and temporary, and it varies between individuals. There is no cure for aging and no guaranteed outcome. A responsible consultation will frame things this way rather than promising dramatic, permanent change.
Aube Clinic is a non-surgical aesthetic-medicine clinic in Seoul where Dr. SuHyun Kim personally performs procedures and consultations. If you want to understand which products and techniques might be discussed for your situation, and how regulatory status is explained, a one-on-one consultation is the right place to ask. You can learn more on the Aube Clinic about-us page or reach the team through the contact-us page. Ask questions directly, and expect straightforward answers.
How to read regulatory claims wisely
When you see the letters "FDA" in aesthetic-medicine marketing, pause and ask three questions. First, which exact product is being described — the specific brand name matters, as the Silhouette Soft versus Silhouette InstaLift example shows. Second, is it "cleared" or "approved," and for what indication? Third, does the claim apply to the US market, or is it referencing another country's rules? Asking these questions protects you from the most common ways regulatory language gets oversimplified. If a claim cannot survive those three questions, treat it with healthy caution and ask the clinic to clarify in writing. If you would like to raise these questions with Aube Clinic before booking, you can reach the team through the contact-us page.
Frequently Asked Questions
Is Silhouette Soft FDA-cleared in the United States?
No. Silhouette Soft, the brand used in Korea and other non-US markets, is not US-FDA-cleared. Availability in Korea reflects Korean regulation, which is separate from US-FDA status. Do not assume the two are the same.
What is Silhouette InstaLift, and is it FDA-cleared?
Silhouette InstaLift is a related but separate product marketed in the United States. It received FDA 510(k) clearance under number K142061 in 2015 for use in mid-face suspension to fixate the cheek subdermis in an elevated position. It is not the same product as Silhouette Soft.
What is the difference between FDA "cleared" and "approved"?
"Cleared" usually refers to devices that pass the 510(k) pathway by showing substantial equivalence to a device already on the US market, as with Silhouette InstaLift. "Approved" generally refers to higher-risk devices and drugs that go through the more rigorous premarket approval process requiring independent evidence of safety and effectiveness. The terms are not interchangeable.
Does FDA clearance mean a thread lift is a facelift?
No. Silhouette InstaLift's cleared indication is a specific, temporary midface fixation, not a facelift. Thread lifts in general are minimally invasive and are not a substitute for surgery. Results are modest, gradual, temporary, and vary between individuals.
Does clearance for InstaLift make Silhouette Soft FDA-cleared too?
No. FDA clearance applies to a specific product and a specific indication. A clearance granted to Silhouette InstaLift does not transfer to Silhouette Soft, which is a differently named product for non-US markets.
Is a product used in Korea automatically FDA-cleared?
No. Regulatory status is country-specific. Korea has its own regulatory authority, and a product used legally in Korea is used under Korean rules, which is not the same as holding US-FDA clearance or approval.
Does FDA clearance guarantee a good result for me?
No. Regulatory clearance describes a defined pathway and indication; it is not a guarantee of any outcome and not a ranking of quality. Your results depend on your anatomy, the treatment plan, and honest, realistic expectations discussed with a qualified physician.
The Bottom Line
- Silhouette Soft (used in Korea) is not US-FDA-cleared. Being available in Korea does not confer US-FDA status.
- Silhouette InstaLift is US-FDA-cleared under 510(k) number K142061 for a specific temporary midface fixation indication — it is a different product and not a facelift.
- "Cleared" (510(k), substantial equivalence) is not the same as "approved" (premarket approval), and clearance always applies to a specific indication.
- Regulatory status is country-specific; US-FDA rules and Korean rules are separate, and neither status implies superiority or a guaranteed result.
- Ask clinics to specify the exact product, whether it is cleared or approved, and for which indication and market.
This article is for general educational purposes about non-surgical aesthetic medicine and does not constitute medical advice. Regulatory information can change over time, results vary from person to person, and nothing here promises any particular outcome. It is not a self-diagnosis tool. For guidance about your own care and about the specific products a clinic uses, consult a qualified physician and confirm details directly with the clinic.
Clinical Safety Notice & Personalized 1:1 Consultation
All aesthetic and regenerative procedures at Aube Clinic (Hoban Summit Edition 2F, 66 Hangang-daero, Yongsan-gu, Seoul) are planned and performed 1:1 by Representative Director Dr. Suhyun Kim after direct facial anatomy and skin evaluation. Treatment outcomes and recovery timelines vary by individual tissue condition, and temporary swelling, bruising, redness, tenderness, or asymmetry may occur.
1:1 Consultation